Oncology
Carcinoembryonic Antigen (CEA)
The Carcinoembryonic Antigen Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of CEA in serum, plasma or whole blood. It is intended as an aid in the assessment and diagnosis of colorectal cancer and other types of cancers, such as pancreatic, stomach, breast, lung, and certain types of thyroid and ovarian cancer. The CEA rapid test device utilizes a combination of colloidal gold conjugate and monoclonal antibodies to selectively detect elevated levels of CEA.
Key Benefits:
– Two band results for simple interpretation.
– Detects carcinoembryonic antigen.
– Room temperature storage or refrigerated (2-30⁰C).
– Internal control included.
– Reagents included.
Specifications:
– Cut-off: 5 ng/mL
– Sensitivity: 98.5%
– Specificity: 98.6%
– Specimen: Whole Blood, Serum, Plasma
– Time to Results: 10 minutes
– Shelf Life: 24 months from the date of manufacture
The Carcinoembryonic Antigen Rapid Test is not available for sale in the US. For EU and other countries Please contact us for more information.
Ordering Information
| Product Description | Specimen | Catalog No. | Format | Cut-off Value | Kit Size |
| Carcinoembryonic Antigen Rapid Test | S/P | GECEA-301a | Strip | 5 ng/mL | 50 Tests/Kit |
| Carcinoembryonic Antigen Rapid Test | S/P | GECEA-302a | Cassette | 5 ng/mL | 25 Tests/Kit |
| Carcinoembryonic Antigen Rapid Test | WB/S/P | GECEA-401a√ | Strip | 5 ng/mL | 50 Tests/Kit |
| Carcinoembryonic Antigen Rapid Test | WB/S/P | GECEA-402a√ | Cassette | 5 ng/mL | 25 Tests/Kit |